Platform Technologies and the Collaboration Paradox
Executive Summary
For all the innovations they promise in a drug industry with me-too products, the fact remains that contemporary drug discovery technologies increase the time required to produce a new drug. In genomics, companies now pursue their own targets, looking to create as much intellectual property around them as possible. They thereby keep their competitors away from the field--but they also lose their help.